Flow acquires brain stimulation technology developer Halo (Medical Device Network):
Flow Neuroscience has acquired the assets of brain stimulation technology developer Halo Neuroscience to advance its research into depression and other mental health disorder treatments.
The financial details of the deal have not been disclosed.
Using Halo’s research in neuromodulation field, Flow Neuroscience plans to enhance its current medically certified tDCS headset for depression … A form of neuromodulation, tDCS uses constant, low direct current delivered via electrodes on the head.
In July 2019, Flow announced that it raised $1.5m towards its transcranial direct current stimulation (tDCS) device for the treatment of depression.
News in Context:
- Halo Neuroscience raises $13M to further develop and commercialize neuromodulation headset
- tDCS coming to an Equinox gym near you: Good, Bad or Depends?
- Important insights on the growing home use of tDCS brain stimulation: older-than-expected users, positive self-reported results for treatment of depression but negative for self-enhancement, and a couple areas of concern (severe burns, frequency)
- Pros and Cons of latest wearable tech trend: Mood-altering electrical brain stimulation
- Too early? Brain stimulation device Thync fails to get traction in the minds of consumers
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright